Pfizer expands Singapore nutrition plant
This article was originally published in The Tan Sheet
Executive SummaryPfizer invests $100 million to expand its Singapore nutrition plant to better serve key markets including China, Indonesia, Malaysia, Pakistan and Vietnam. The investment increased the plant's production capacity by 50 percent and expanded the facility to 91,963 square meters, according to a July 7 announcement. Pfizer added the nutritional business, including infant formulas Promil Gold, SMA and Nursoy, to its portfolio when it acquired Wyeth in October 2009 (1"The Tan Sheet" Oct. 26, 2009). Last May the company said it will stop operating eight other manufacturing sites by 2015 and plans to reduce activities at six others by the end of 2012 (2"The Tan Sheet" May 24, 2010)
You may also be interested in...
A BLA filing for Zynteglo in beta-thalassemia is expected in the second half of 2020 instead of the first half, but the first commercial patient in the EU will be treated in the first half of this year.